Europe Diabetes Care Devices Investment Opportunities, Analysis and Forecasts to 2015

Europe Diabetes Care Devices Investment Opportunities, Analysis and Forecasts to 2015

Europe Diabetes Care Devices Investment Opportunities, Analysis and Forecasts to 2015

Summary

This report is an essential source for in-depth information and data relating to Europe diabetes care devices market. It also offers detailed and comprehensive coverage of market revenue, volume, distribution and company share information; and the latest news, financial deals and pipeline products information of each of the key sub-segments of the diabetes care devices market in Europe

Scope

- The report provides diabetes care devices information broken down into detailed categories in Europe.
- Total revenues, products sold and end users.
- Market shares of all the key competitors.
- Key pipeline products that are set to shape the market, broken down by sector.
- Information on the top medical equipment companies in the sector in the country covering business description, strategic analysis, and financial information.
- Healthcare structure, regulatory environment, approval process, pricing trends and reimbursement.
- Product and brand updates, strategy changes, R&D projects, corporate expansions and contractions and regulatory changes.
- Key mergers and acquisitions, partnerships, private equity investments and IPOs.
- Customer, hospitals and physicians data.

Reasons to buy

- Gain a strong understanding of the diabetes care devices market in Europe.
- Evaluate and compare the attractiveness of the market in the region.
- Identify growth segments and opportunities in each industry sector within the region.
- Evaluate the pipeline of key products that will change the sector, and identify threats and opportunities before the products are launched in the region.
- Analyze the competitiveness of the market in the region and identify hotspots.
- Develop strategies based on the latest product, brand, expansion and research and development news in the region.
- Do deals with an understanding of how competitors are financed, and the mergers and partnerships that have shaped the market in the region.
- Identify and analyze the strengths and weaknesses of the industry incumbents in the region.

1 Table of Contents
1 Table of Contents 2
1.1 List of Tables 8
1.2 List of Figures 12
2 Introduction 15
2.1 What Is This Report About? 15
3 Definitions of Markets Covered in the Report 16
3.1 Diabetic Care Devices 16
3.2 Glucose Monitoring Devices 16
3.3 Insulin Delivery 16
4 Diabetes Care Devices in Europe 17
4.1 Diabetes Care Devices, Europe, Overall Revenue ($ mn), 2000-2015 17
4.2 Diabetes Care Devices, Europe, Category Volume (Units), 2000-2015 21
4.3 Diabetes Care Devices, Europe, Company share (2007-2008) 24
5 Diabetes Care Devices In Germany 25
5.1 Diabetes Care Devices, Germany, Overall Revenue ($ mn), 2000-2015 25
5.2 Diabetes Care Devices, Germany, Category Volume (Units), 2000-2015 28
5.3 Diabetes Care Devices, Germany, Distribution Share (2007-2008) 31
5.3.1 Glucose Monitoring Distribution Share (2007-2008) 31
5.3.2 Insulin Delivery Distribution Share (2007-2008) 31
5.4 Diabetes Care Devices, Germany, Company Share (2007-2008) 32
5.4.1 Diabetes Care Devices, Germany, Company Share (2007-2008) 32
5.4.2 Glucose Monitoring, Germany, Company Share (2007-2008) 33
5.4.3 Insulin Delivery, Germany, Company Share (2007-2008) 34
6 Diabetes Care Devices In Italy 35
6.1 Diabetes Care Devices, Italy, Overall Revenue ($ mn), 2000-2015 35
6.2 Diabetes Care Devices, Italy, Category Volume (Units), 2000-2015 39
6.3 Diabetes Care Devices, Italy, Distribution Share (2007-2008) 42
6.3.1 Glucose Monitoring Distribution Share (2007-2008) 42
6.3.2 Insulin Delivery Distribution Share (2007-2008) 42
6.4 Diabetes Care Devices, Italy, Company Share (2007-2008) 43
6.4.1 Diabetes Care Devices, Italy, Company Share (2007-2008) 43
6.4.2 Glucose Monitoring, Italy, Company Share (2007-2008) 44
6.4.3 Insulin Delivery, Italy, Company Share (2007-2008) 45
7 Diabetes Care Devices In France 46
7.1 Diabetes Care Devices, France, Overall Revenue ($ mn), 2000-2015 46
7.2 Diabetes Care Devices, France, Category Volume (Units), 2000-2015 49
7.3 Diabetes Care Devices, France, Distribution Share (2007-2008) 52
7.3.1 Glucose Monitoring Distribution Share (2007-2008) 52
7.3.2 Insulin Delivery Distribution Share (2007-2008) 52
7.4 Diabetes Care Devices, France, Company Share (2007-2008) 53
7.4.1 Diabetes Care Devices, France, Company Share (2007-2008) 53
7.4.2 Glucose Monitoring, France, Company Share (2007-2008) 54
7.4.3 Insulin Delivery, France, Company Share (2007-2008) 55
8 Diabetes Care Devices In United Kingdom 56
8.1 Diabetes Care Devices, United Kingdom, Overall Revenue ($ mn), 2000-2015 56
8.2 Diabetes Care Devices, United Kingdom, Category Volume (Units), 2000-2015 59
8.3 Diabetes Care Devices, United Kingdom, Distribution Share (2007-2008) 62
8.3.1 Glucose Monitoring Distribution Share (2007-2008) 62
8.3.2 Insulin Delivery Distribution Share (2007-2008) 62
8.4 Diabetes Care Devices, United Kingdom, Company Share (2007-2008) 63
8.4.1 Diabetes Care Devices, United Kingdom, Company Share (2007-2008) 63
8.4.2 Glucose Monitoring, United Kingdom, Company Share (2007-2008) 64
8.4.3 Insulin Delivery, United Kingdom, Company Share (2007-2008) 65
9 Diabetes Care Devices In Spain 66
9.1 Diabetes Care Devices, Spain, Overall Revenue ($ mn), 2000-2015 66
9.2 Diabetes Care Devices, Spain, Category Volume (Units), 2000-2015 69
9.2.1 Diabetes Care Devices, Spain, Distribution Share (2007-2008) 72
9.2.2 Glucose Monitoring Distribution Share (2007-2008) 72
9.2.3 Insulin Delivery Distribution Share (2007-2008) 72
9.3 Diabetes Care Devices, Spain, Company Share (2007-2008) 73
9.3.1 Diabetes Care Devices, Spain, Company Share (2007-2008) 73
9.3.2 Glucose Monitoring, Spain, Company Share (2007-2008) 74
9.3.3 Insulin Delivery, Spain, Company Share (2007-2008) 75
10 Diabetes Care Devices In Netherlands 76
10.1 Diabetes Care Devices, Netherlands, Overall Revenue ($ mn), 2000-2015 76
10.2 Diabetes Care Devices, Netherlands, Category Volume (Units), 2000-2015 80
10.3 Diabetes Care Devices, Netherlands, Distribution Share (2007-2008) 83
10.3.1 Glucose Monitoring Distribution Share (2007-2008) 83
10.3.2 Insulin Delivery Distribution Share (2007-2008) 83
10.4 Diabetes Care Devices, Netherlands, Company Share (2007-2008) 84
10.4.1 Diabetes Care Devices, Netherlands, Company Share (2007-2008) 84
10.4.2 Glucose Monitoring, Netherlands, Company Share (2007-2008) 85
10.4.3 Insulin Delivery, Netherlands, Company Share (2007-2008) 86
11 Diabetes Care Devices In Belgium 87
11.1 Diabetes Care Devices, Belgium, Overall Revenue ($ mn), 2000-2015 87
11.2 Diabetes Care Devices, Belgium, Category Volume (Units), 2000-2015 90
11.3 Diabetes Care Devices, Belgium, Distribution Share (2007-2008) 93
11.3.1 Glucose Monitoring Distribution Share (2007-2008) 93
11.3.2 Insulin Delivery Distribution Share (2007-2008) 93
11.4 Diabetes Care Devices, Belgium, Company Share (2007-2008) 94
11.4.1 Diabetes Care Devices, Belgium, Company Share (2007-2008) 94
11.4.2 Glucose Monitoring, Belgium, Company Share (2007-2008) 95
11.4.3 Insulin Delivery, Belgium, Company Share (2007-2008) 96
12 Overview of Key Companies in Europe Diabetes Care Devices Market 97
12.1 F. Hoffmann-La Roche Ltd. 97
12.1.1 Company Overview 97
12.1.2 Value Chain Analysis 98
12.1.3 F. Hoffmann-La Roche Ltd Pipeline Products 100
12.2 Bayer HealthCare AG 101
12.2.1 Company Overview 101
12.2.2 Value Chain Analysis 102
12.2.3 Bayer HealthCare AG Pipeline Products 104
12.3 LifeScan, Inc. 105
12.3.1 Company Overview 105
12.3.2 LifeScan, Inc. Pipeline Products 105
12.4 Abbott Laboratories 107
12.4.1 Company Overview 107
12.4.2 Value Chain Analysis 108
12.4.3 Abbott Laboratories Pipeline Products 110
12.5 Medtronic, Inc. 112
12.5.1 Company Overview 112
12.5.2 Value Chain Analysis 113
12.5.3 Medtronic, Inc. Pipeline Products 115
12.6 Novo Nordisk A/S 123
12.6.1 Company Overview 123
12.6.2 Novo Nordisk A/S Pipeline Products 123
12.7 ARKRAY, Inc. 125
12.7.1 Company Overview 125
12.7.2 ARKRAY, Inc. Pipeline Products 125
12.8 Becton, Dickinson and Company 127
12.8.1 Company Overview 127
12.8.2 Value Chain Analysis 127
12.9 Eli Lilly and Company 129
12.9.1 Company Overview 129
12.9.2 Value Chain Analysis 129
12.9.3 Eli Lilly and Company Pipeline Products 132
12.10 Terumo Corporation 133
12.10.1 Company Overview 133
12.10.2 Value Chain Analysis 133
12.11 Animas Corporation 135
12.11.1 Company Overview 135
12.12 Sanofi-Aventis 135
12.12.1 Company Overview 135
12.13 Smiths Medical 136
12.13.1 Company Overview 136
12.13.2 Value Chain Analysis 137
12.14 Apex Biotechnology Corp. 139
12.14.1 Company Overview 139
12.15 Panasonic Corporation 139
12.15.1 Company Overview 139
12.16 A. Menarini Diagnostics S.r.l. 140
12.16.1 Company Overview 140
12.16.2 A. Menarini Diagnostics S.r.l. Pipeline Products 140
12.17 EKF-diagnostic GmbH 142
12.17.1 Company Overview 142
12.18 Diabetes Management International BV 142
12.18.1 Company Overview 142
13 Financial Deals Landscape 143
13.1 Partnerships 143
13.1.1 Amylin Pharmaceuticals Plans to Enter Into an Agreement with Eli Lilly 143
14 Appendix 144
14.1 Global Markets Direct Research Methodology 144
14.2 Coverage 145
14.3 Secondary Research 145
14.4 Primary Research 146
14.5 Models 146
14.6 Forecasts 147
14.7 Expert Panel Validation 147
14.8 Currency Conversion 148
14.9 Contact Us 149
14.10 Disclaimer 149